These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4005134)

  • 21. Gastric, intestinal and colonic absorption of metoprolol in the rat.
    Doménech J; Alba M; Morera JM; Obach R; Plá Delfina JM
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):85S-89S. PubMed ID: 4005133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.
    Hirtz J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):77S-83S. PubMed ID: 3890912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum.
    Jobin G; Cortot A; Godbillon J; Duval M; Schoeller JP; Hirtz J; Bernier JJ
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):97S-105S. PubMed ID: 4005135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of plasma and saliva levels of metoprolol and oxprenolol.
    Dawes CP; Kendall MJ; John VA
    Br J Clin Pharmacol; 1978 Mar; 5(3):217-21. PubMed ID: 656265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise.
    Bobik A; Jennings GL; Korner PI; Ashley P; Jackman G
    Br J Clin Pharmacol; 1979 Jun; 7(6):545-9. PubMed ID: 465276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.
    Godbillon J; Evard D; Vidon N; Duval M; Schoeller JP; Bernier JJ; Hirtz J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):113S-118S. PubMed ID: 4005112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals.
    Dawes CP; Kendall MJ; Welling PG
    Br J Clin Pharmacol; 1979 Mar; 7(3):299-302. PubMed ID: 427007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric and intestinal absorption of oxprenolol in humans.
    Vidon N; Palma R; Godbillon J; Franchisseur C; Gosset G; Bernier JJ; Hirtz J
    J Clin Pharmacol; 1986; 26(8):611-5. PubMed ID: 3793952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior.
    Ueda S; Ibuki R; Kawamura A; Murata S; Takahashi T; Kimura S; Hata T
    J Drug Target; 1994; 2(2):133-40. PubMed ID: 8069590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
    Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
    Comerford MB; Besterman EM
    Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
    Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
    Rigby JW; Scott AK; Hawksworth GM; Petrie JC
    Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J; Degen PH; Racine-Poon A
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG; Hampton JR
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eudragit FS based colonic microparticls of metoprolol tartrate.
    Rasool F; Ahmad M; Murtaza G; Khan HM; Khan SA
    Acta Pol Pharm; 2012; 69(2):347-53. PubMed ID: 22568051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations.
    Mistry B; Leslie JL; Eddington ND
    Chirality; 2002 May; 14(4):297-304. PubMed ID: 11968069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
    Zur M; Cohen N; Agbaria R; Dahan A
    Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.